Two Sigma Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21M Sell
576,901
-56,251
-9% -$2.05M 0.04% 521
2025
Q1
$22.9M Buy
633,152
+18,204
+3% +$659K 0.05% 426
2024
Q4
$25.9M Sell
614,948
-140,735
-19% -$5.92M 0.06% 382
2024
Q3
$42M Buy
755,683
+187,374
+33% +$10.4M 0.09% 260
2024
Q2
$23.4M Buy
568,309
+152,995
+37% +$6.29M 0.05% 390
2024
Q1
$19.4M Buy
415,314
+288,704
+228% +$13.5M 0.05% 422
2023
Q4
$6.05M Buy
126,610
+87,410
+223% +$4.18M 0.01% 832
2023
Q3
$1.4M Sell
39,200
-364,574
-90% -$13M ﹤0.01% 1660
2023
Q2
$18.6M Sell
403,774
-84,582
-17% -$3.9M 0.05% 397
2023
Q1
$19.6M Buy
488,356
+46,420
+11% +$1.86M 0.06% 367
2022
Q4
$20.5M Buy
441,936
+186,547
+73% +$8.64M 0.06% 337
2022
Q3
$10.6M Buy
255,389
+198,889
+352% +$8.24M 0.04% 464
2022
Q2
$3.37M Buy
56,500
+17,600
+45% +$1.05M 0.01% 893
2022
Q1
$2.83M Buy
+38,900
New +$2.83M 0.01% 1157
2021
Q4
Sell
-25,900
Closed -$2.34M 3015
2021
Q3
$2.34M Sell
25,900
-264,364
-91% -$23.8M 0.01% 1280
2021
Q2
$27.7M Buy
290,264
+145,944
+101% +$13.9M 0.06% 333
2021
Q1
$16.4M Buy
144,320
+84,008
+139% +$9.56M 0.04% 428
2020
Q4
$8.35M Buy
60,312
+54,595
+955% +$7.56M 0.02% 558
2020
Q3
$470K Sell
5,717
-33,837
-86% -$2.78M ﹤0.01% 1444
2020
Q2
$3.09M Buy
+39,554
New +$3.09M 0.02% 726
2019
Q4
Sell
-7,759
Closed -$332K 2452
2019
Q3
$332K Buy
+7,759
New +$332K ﹤0.01% 1608
2017
Q1
Hold
0
2376
2016
Q4
Hold
0
2389
2015
Q4
Sell
-150,113
Closed -$14.5M 2235
2015
Q3
$14.5M Buy
150,113
+4,772
+3% +$460K 0.07% 281
2015
Q2
$14.9M Buy
145,341
+132,520
+1,034% +$13.6M 0.07% 327
2015
Q1
$796K Buy
+12,821
New +$796K ﹤0.01% 1493